RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S

Recursion to Participate in Upcoming Investor Conference

02 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

05 سبتمبر 2023 15:30:00 بحسب Nasdaq GlobeNewswire

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

05 سبتمبر 2023 06:59:00 بحسب Nasdaq GlobeNewswire

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

08 أغسطس 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

08 أغسطس 2023 06:58:00 بحسب Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

01 أغسطس 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

26 يوليو 2023 17:58:00 بحسب Nasdaq GlobeNewswire

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

12 يوليو 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

26 يونيو 2023 10:48:04 بحسب Nasdaq GlobeNewswire

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

13 يونيو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

01 يونيو 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Altitude Lab Relocates to Gateway’s BioHive Hub

25 مايو 2023 15:00:00 بحسب Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

08 مايو 2023 07:14:39 بحسب Nasdaq GlobeNewswire

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

08 مايو 2023 06:59:00 بحسب Nasdaq GlobeNewswire